Exchange: NASDAQ·Updated 03:55 PM EDT
OMCL logo

OMCLOmnicell, Inc.

$46.06
$0.62
(1.33%)
Today
EarningsJul 30
Mkt Cap$2.12B
Vol451,313.00
News
all
press releases
Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the second quarter 2026, before market open on Thursday, July 30, 2026. The Company will host a conference call and webcast to...
Business Wire
News Placeholder
More News
News Placeholder
Should You Continue to Hold OMCL Stock in Your Portfolio Now?
Omnicell is advancing its autonomous pharmacy vision and expanding SaaS offerings, but tariffs and fierce competition could test its growth path.
Zacks
News Placeholder
What's Fueling Omnicell Stock's 52.6% Rally Over the Past Year?
OMCL's autonomous pharmacy strategy, SaaS growth and global expansion boost shares. Can rising costs and tariffs slow the momentum?
Zacks
News Placeholder
Nnamdi Njoku Appointed President of Omnicell
Omnicell, Inc. (NASDAQ:OMCL) (Omnicell or the Company), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Nnamdi Njoku has been appointed President of the Company, effective July 1, 2026. Mr. Njoku will retain his role of Chief...
Business Wire
News Placeholder
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Zacks
News Placeholder
Do Options Traders Know Something About Omnicell Stock We Don't?
Investors need to pay close attention to OMCL stock based on the movements in the options market lately.
Zacks
News Placeholder
OMCL vs. HIMS: Which Stock Is the Better Value Option?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Zacks
News Placeholder
Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
News Placeholder
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
Omnicell, Inc. (NASDAQ:OMCL) (Omnicell or the Company), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Dan Mandoli, a seasoned healthcare executive with more than 30 years of leadership across pharmacy operations and specialty...
Business Wire
<
1
2
...
>